mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.01 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |